Mesenchymal stem cells secretome as a prospective therapeutic option for COVID-19 patients 10SHARES Share via Pinterest Reddit Buffer Xing WhatsApp Flipboard Posted: 13 April 2020 | Avinash Kharat (Dr D Y Patil Vidyapeeth), Avinash Sanap ( Dr D Y Patil Vidyapeeth), Dr Ramesh Bhonde (Dr D Y Patil Vidyapeeth), Supriya Kheur (Dr D Y Patil Vidyapeeth) | 1 comment Researchers propose using mesenchymal stem cells to counter the pro-inflammatory cytokines associated with COVID-19 coronavirus symptoms. To read the research, click here. With regular news updates and feature articles, our COVID-19 hub has everything you need to keep up to date with R&D during the pandemic. Click below to visit: COVID-19 hub Related topicsDrug Targets, Research & Development, Stem Cells, Therapeutics Related conditionsCoronavirus, Covid-19